A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (NAVIGATOR).
- Gillman, Andrew (Primary Chief Investigator (PCI))
- Hazard, Anita (Project Manager)
Project: Research